Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy

References

• Altice , F.L. , Maru , D.S. , Bruce , R.D. , Springer , S.A. and Friedland , G.H. 2007 . Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: A prospective, randomized, controlled trial . Clinical Infectious Disease , 45 ( 6 ) : 770 – 778 .
   PubMed Web of Science ®Google Scholar
• Altice , F.L. , Mezger , J.A. , Hodges , J. , Bruce , R.D. , Marinovich , A. Walton , M. 2004 . Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: Implications for program replication . Clinical Infectious Disease , 38 ( Suppl. 5 ) : 376 – 387 .
   PubMed Web of Science ®Google Scholar
• Bangsberg , D.R. , Moss , A. and Deeks , S. 2004 . Paradoxes of adherence and drug resistance to HIV antiretroviral therapy . Journal of Antimicrobial Chemotherapy , 53 : 696 – 699 .
   PubMed Web of Science ®Google Scholar
• Berger-Greenstein , J.A. , Cuevas , C.A. , Brady , S.M. , Trezza , G. , Richardson , M.A. and Keane , T.M. 2007 . Major depression in patients with HIV/AIDS and substance abuse . AIDS Patient Care STDS , 21 ( 12 ) : 942 – 955 .
   PubMed Web of Science ®Google Scholar
• Bouhnik , A.D. , Preau , M. , Vincent , E. , Carrieri , M.P , Gallais , H Lepeu , G . 2005 . Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy . Antiviral Therapy , 10 ( 1 ) : 53 – 61 .
   PubMed Web of Science ®Google Scholar
• Boyd , J.H. , Weissman , M.M. , Thompson , W.D. and Myers , J.K. 1982 . Screening for depression in a community sample. Understanding the discrepancies between depression symptom and diagnostic scales . Archives of General Psychiatry , 39 ( 10 ) : 1195 – 1200 .
   PubMed Web of Science ®Google Scholar
• Burack , J.H. , Barrett , D.C. , Stall , R.D. , Chesney , M.A. , Ekstrand , M.L. and Coates , T.J. 1993 . Depressive symptoms and CD4 lymphocyte decline among HIV-infected men . JAMA , 270 ( 21 ) : 2568 – 2573 .
   PubMed Web of Science ®Google Scholar
• Catz , S. , Kelly , J.A. , Bogart , L. , Benotsch , E. and McAuliffe , T. 2000 . Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease . Health Psychology , 19 : 124 – 133 .
   PubMed Web of Science ®Google Scholar
• Chesney , M.A. , Ickovics , J.R. , Chambers , D.B. , Gifford , A.L. , Neidig , J Zwickl , B . 2000 . Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments . AIDS Care , 12 : 255 – 266 .
   PubMed Web of Science ®Google Scholar
• Ciesla , J.A. and Roberts , J.E. 2001 . Meta-analysis of the relationship between HIV infection and risk for depressive disorders . American Journal of Psychiatry , 158 ( 5 ) : 725 – 730 .
   PubMed Web of Science ®Google Scholar
• Cohen , R.A. , Boland , R. , Paul , R. , Tashima , K.T. , Schoenbaum , E.E. Celentano , D.D. 2001 . Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women . AIDS , 15 ( 3 ) : 341 – 345 .
   PubMed Web of Science ®Google Scholar
• Cook , J.A. , Grey , D. , Burke , J. , Cohen , M.H. , Gurtman , A.C. Richardson , J.L. 2004 . Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women . American Journal of Public Health , 94 ( 7 ) : 1133 – 1140 .
   PubMed Web of Science ®Google Scholar
• Cruess , S. , Antoni , M. , Hayes , A. , Penedo , F. , Ironson , G. Fletcher , M.A. 2002 . Changes in mood and depressive symptoms and related change processes during cognitive-behavioral stress management in HIV infected men . Cognitive Therapy Research , 26 : 373 – 392 .
   Web of Science ®Google Scholar
• Fechner-Bates , S. , Coyne , J.C. and Schwenk , T.L. 1994 . The relationship of self-reported distress to depressive disorders and other psychopathology . Journal of Consulting and Clinical Psychology , 62 ( 3 ) : 550 – 559 .
   PubMed Web of Science ®Google Scholar
• Himelhoch , S. and Medoff , D.R. 2005 . Efficacy of antidepressant medication among HIV-positive individuals with depression: A systematic review and meta-analysis . AIDS Patient Care STDS , 19 ( 12 ) : 813 – 822 .
   PubMed Web of Science ®Google Scholar
• Hollon , S.D. , DeRubeis , R.J. , Shelton , R.C. , Amsterdam , J.D. , Salomon , R.M. O'Reardon , J.P. 2005 . Prevention of relapse following cognitive therapy vs medications in moderate to severe depression . Archives of General Psychiatry , 62 ( 4 ) : 417 – 422 .
   PubMed Web of Science ®Google Scholar
• Huba , G.J. , & Melchior , L.A. 1996 . Staff of the Measurement Group, HRSA/HAB's SPNS Cooperative Agreement Steering Committee. Module 64: Self-Efficacy Form . Retrieved April 10, 2008, from www.TheMeasurementGroup.com
   Google Scholar
• Ickovics , J.R. , Hamburger , M.E. , Vlahov , D. , Schoenbaum , E.E. , Schuman , P. Boland , R.J. 2001 . Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: Longitudinal analysis from the HIV Epidemiology Research Study . JAMA , 285 ( 11 ) : 1466 – 1474 .
   PubMed Web of Science ®Google Scholar
• Johnson , J.G. , Rabkin , J.G. , Lipsitz , J.D. , Williams , J.B. and Remien , R.H. 1999 . Recurrent major depressive disorder among human immunodeficiency virus (HIV)-positive and HIV-negative intravenous drug users: Findings of a 3-year longitudinal study . Comparitive Psychiatry , 40 ( 1 ) : 31 – 34 .
   PubMed Web of Science ®Google Scholar
• Knowlton , A.R. , Latkin , C.A. , Schroeder , J.R. , Hoover , D.R. , Ensminger , M. and Celentano , D.D. 2001 . Longitudinal predictors of depressive symptoms among low income injection drug users . AIDS Care , 13 ( 5 ) : 549 – 559 .
   PubMed Web of Science ®Google Scholar
• Kozal , M.J. , Amico , K.R. , Chiarella , J. , Cornman , D. , Fisher , W. Fisher , J. 2005 . HIV drug resistance and HIV transmission risk behaviors among active injection drug users . Journal of Acquired Immuno Deficiency Syndrome , 40 ( 1 ) : 106 – 109 .
   PubMed Web of Science ®Google Scholar
• Kushel , M.B. , Colfax , G. , Ragland , K. , Heineman , A. , Palacio , H. and Bangsberg , D.R. 2006 . Case management is associated with improved antiretroviral adherence and CD4+ cell counts in homeless and marginally housed individuals with HIV infection . Clinical Infectious Disease , 43 ( 2 ) : 234 – 242 .
   PubMed Web of Science ®Google Scholar
• Maru , D.S. , Bruce , R.D. , Walton , M. , Mezger , J.A. , Springer , S.A. Shield , D. 2008 . Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy . AIDS Behaviour , 12 ( 2 ) : 284 – 293 .
   PubMed Web of Science ®Google Scholar
• Maru , D.S. , Kozal , M.J. , Bruce , R.D. , Springer , S.A. and Altice , F.L. 2007 . Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: Results from a randomized controlled trial . Journal of Acquired Immune Deficiency Syndrome , 46 ( 5 ) : 555 – 563 .
   PubMed Web of Science ®Google Scholar
• Moatti , J. , Carrieri , M. , Spire , B. , Gastault , J.A. , Cassuto , J.P. Moreau , J. 2000 . Adherence to HAART in French HIV-infected injecting drug users: The contribution of buprenorphine drug maintenance treatment . AIDS and Behavior , 14 : 151 – 155 .
   Web of Science ®Google Scholar
• Olatunji , B. , Mimiaga , M. , O'Cleirigh , C. and Safren , S. 2006 . A review of treatment studies of depression in HIV . Topics in HIV Medicine , 14 ( 3 ) : 112 – 124 .
   PubMedGoogle Scholar
• Perdue , T. , Hagan , H. , Thiede , H. and Valleroy , L. 2003 . Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men . AIDS Education Preview , 15 ( 1 ) : 81 – 92 .
   PubMed Web of Science ®Google Scholar
• Radloff , L.S. 1977 . The CES-D scale: A self report depression scale for research in the general population . Applied Psychological Measurement , 1 : 385 – 401 .
   Web of Science ®Google Scholar
• Sacktor , N. , Nakasujja , N. , Skolasky , R. , Robertson , K. , Wong , M. Musisi , S. 2006 . Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa . Neurology , 67 ( 2 ) : 311 – 314 .
   PubMed Web of Science ®Google Scholar
• Skinner , H.A. 1982 . The drug abuse screening test . Addict Behaviour , 7 ( 4 ) : 363 – 371 .
   PubMed Web of Science ®Google Scholar
• Smith-Rohrberg , D. , & Altice , F.L. 2006 . Randomized, controlled trials of directly administered antiretroviral therapy for HIV-infected patients: Questions about study population and analytical approach . Clinical Infectious Diseases , 43 ( 9 ), 1221 1222 ; author reply 1222–1223 .
   PubMed Web of Science ®Google Scholar
• Smith-Rohrberg , D. , Mezger , J. , Walton , M. , Bruce , R.D. and Altice , F.L. 2006 . Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users . Journal of Acquired Immuno Deficiency Syndrome Human Reterovirology , 43 ( Suppl. 1 ) : 48 – 53 .
   PubMed Web of Science ®Google Scholar
• Suarez , S. , Baril , L. , Stankoff , B. , Khellaf , M. , Dubois , B. Lubetzki , C. 2001 . Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy . AIDS , 15 ( 2 ) : 195 – 200 .
   PubMed Web of Science ®Google Scholar